The.Bird@f38.n135.z1.fidonet.org (The "Bird") (10/22/90)
I remember hearing bits of a presentation by one of the Salk associates at the
S.F. AIDS Conference. My memory tells me that they had pretty much given up on
the seropositive application as being ineffective.
Does anyone have that presentation or a reference to it's publication? I don't
want to spread false statements cause I "heard it somewhere".
Also, are the conference abstracts published anywhere? If so, how can I get
them. Are they expensive? Available by subject? I need some new
reading/reference material <grin>.
"Bird"
--
Uucp: ...{gatech,ames,rutgers}!ncar!asuvax!stjhmc!135!38!The."Bird"
Internet: The."Bird"@f38.n135.z1.fidonet.orgrhc@PacBell.COM (Robert Cohen) (10/28/90)
In article <40546@shemp.CS.UCLA.EDU> The.Bird@f38.n135.z1.fidonet.org (The "Bird") writes:
->I remember hearing bits of a presentation by one of the Salk associates at the
->S.F. AIDS Conference. My memory tells me that they had pretty much given up on
->the seropositive application as being ineffective.
->
->Does anyone have that presentation or a reference to it's publication? I don't
->want to spread false statements cause I "heard it somewhere".
Bird,
I can't help with the abstracts, but do know that Salk's firm(?), Immune
Response, in La Jolla, CA is planning phase II trials with sero-positives.
Call their info line at 800-422-5448 for recorded details.
If you find out more, through the abstracts, or however, please post.
--
Robert Cohen San Francisco, California rhc@PacBell.COM
{att,bellcore,sun,ames,pyramid}!pacbell!rhc
work: 415-542-5517 home: 553-4033